Potassium

Potassium

SCHEMBL9213987

Cc1ccc(S(=O)(=O)N2C[C@H](O)C[C@H]2C(=O)O)cc1.[K]

nearest known ligand 0.56

Full drug profile on Sugi Atlas →

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.56
MMP2 P08253 3/20 0.55
KMT2A Q03164 4/20 0.53
MEN1 O00255 2/20 0.53
L3MBTL1 Q9Y468 2/20 0.49
MCOLN3 Q8TDD5 1/20 0.49
ALDH1A1 P00352 5/20 0.47
LMNA P02545 1/20 0.46
TSHR P16473 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
ANPEP P15144 1/20 0.45
MMP1 P03956 1/20 0.44
ADAM17 P78536 1/20 0.44
CA12 O43570 1/20 0.44
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44
CA9 Q16790 1/20 0.44
HTT P42858 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21551179 0.99 POLB (0.58) POLBMMP2KMT2AMEN1L3MBTL1
SCHEMBL9379038 0.99 POLB (0.58) POLBMMP2KMT2AMEN1L3MBTL1
SCHEMBL9379041 0.99 POLB (0.58) POLBMMP2KMT2AMEN1L3MBTL1
SCHEMBL11458196 0.99 POLB (0.58) POLBMMP2KMT2AMEN1L3MBTL1
SCHEMBL9215362 0.99 POLB (0.58) POLBMMP2KMT2AMEN1L3MBTL1
SCHEMBL9215368 0.99 POLB (0.58) POLBMMP2KMT2AMEN1L3MBTL1
SCHEMBL9213961 0.97 POLB (0.56) POLBMMP2KMT2AMEN1L3MBTL1
Potassium Ion SCHEMBL9213967 0.86 KMT2A (0.53) POLBMMP2KMT2AMEN1L3MBTL1
SCHEMBL5497274 0.85 MMP2 (0.53) POLBMMP2KMT2AMEN1L3MBTL1
SCHEMBL5497278 0.85 MMP2 (0.53) POLBMMP2KMT2AMEN1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0345808-B1 1-Indolylalkyl-4-(substituted-pyridinyl)piperazines BRISTOL MYERS SQUIBB CO (US) 1995-01-11 EP disclosed
US-4994460-A Treatment or prevention of disorders resulting from central nervous system anoxia BRISTOL-MYERS SQUIBB CO. (US) 1991-02-19 US disclosed
EP-0400661-A1 Agents for treatment of brain ischemia Bristol-Myers Squibb Company (US) 1990-12-05 EP disclosed
US-4954502-A Antidepressants BRISTOL-MYERS SQUIBB COMPANY (US) 1990-09-04 US disclosed
EP-0345808-A1 1-Indolylalkyl-4-(substituted-pyridinyl)piperazines Bristol-Myers Squibb Company (US) 1989-12-13 EP disclosed